FDA Reviewing Roflumilast for Atopic Dermatitis in Toddlers ...Middle East

Medscape - News
FDA Reviewing Roflumilast for Atopic Dermatitis in Toddlers
Topical roflumilast, 0.05%, is under consideration for treating mild to moderate atopic dermatitis in children aged 2-5 years. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Reviewing Roflumilast for Atopic Dermatitis in Toddlers )

Also on site :



Latest News